عنوان
پدید آورنده
موضوع
رده
QP106.6 .A525 2000eb
QP106
.
6
.
A525
2000eb
کتابخانه
محل استقرار
INTERNATIONAL STANDARD BOOK NUMBER
(Number (ISBN
0585415439
(Number (ISBN
1587063441
(Number (ISBN
1597341703
(Number (ISBN
9780585415437
(Number (ISBN
9781587063442
(Number (ISBN
9781597341707
Erroneous ISBN
1587060221
Erroneous ISBN
9781587060229
NATIONAL BIBLIOGRAPHY NUMBER
Number
b775315
TITLE AND STATEMENT OF RESPONSIBILITY
Title Proper
Angiogenesis inhibitors and stimulators :
General Material Designation
[Book]
Other Title Information
potential therapeutic implications /
First Statement of Responsibility
Shaker A. Mousa [editor].
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Austin, Tex. :
Name of Publisher, Distributor, etc.
Eurekah.com,
Date of Publication, Distribution, etc.
©2000.
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
1 online resource ([xi], 162 pages) :
Other Physical Details
illustrations
SERIES
Series Title
Medical intelligence unit ;
Volume Designation
20
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references and index.
CONTENTS NOTE
Text of Note
Front Cover -- Inside Cover -- Copyright -- Table of Contents -- Editors / Contributors -- Preface -- Chapter 1: Mechanims of Angiogenesis -- Chapter 2: Angiogenisis and Ischemia -- Chapter 3: The Role of Smooth Muscle Cells and Pericytes in Angiogenesis -- Chapter 4: Integrin v in Health and Disease-Role of v3 in Metastasis, Vascular Remodeling and Angiogenesis -- Chapter 5: PECAM-1 and Angiogenesis -- Chapter 6: Thrombospondin and Angiogenesis -- Chapter 7: The Role of Vascular Endothelial Growth Factor in Angiogenesis -- Chapter 8: Regulation of Angiogenesis by Fibroblast Growth Factors.
Text of Note
Angiogenesis inhibitor -- Antiangiogenesis -- Apoptosis -- Atherosclerosis -- avb3 -- avb5 -- Cancer -- Cell adhesion molecules -- CM-101 123, 145 -- Collateral -- Combinatorial chemical libraries -- Cyclic RGD -- Cytokines -- Cytostatic -- Cytotoxic -- D -- Diabetes -- Diabetic retinopathy -- E -- Endothelial cells -- Endothelial migration -- Extracellular matrix -- F -- FGF 87, -- Fibroblast growth factor (FGF) -- G -- Gene therapy -- Growth factor(s) -- H -- Heparan sulfate -- Hyperoxia 68, 111, 112 -- I -- Imaging -- Immunoglobulin -- Inflammation -- Inflammatory diseases -- Integrins.
Text of Note
Chapter 9: Role of Angiogenesis in Wound Healing -- Chapter 10: Ocular Neovascularization -- Chapter 11: Anti-Angiogenesis Strategies Potential Therapeutic Implications -- Chapter 12: Matrix Metalloproteinase Inhibitors in Angiogenesis-Mediated Disorders with Special Emphasis on Cancer -- Chapter 13: Pharmaceutical Development of an Antiangiogenic Drug-Candidate -- Chapter 14: Surrogate Endpoints as a Measure of Efficacy in Clinical Trials of Angiogenesis Inhibitors -- Chapter 15: Lessons from Clinical Trials of Anti-Angiogenic Drugs in the Treatment of Cancer -- Index -- A -- Angiogenesis.
Text of Note
Ischemia -- M -- Macular degeneration -- Matrix -- Matrix metalloproteinases -- Metastasis -- MMP -- N -- Neuropeptide Y -- O -- Ocular disease -- Oncology -- P -- Pericyte -- Plasminogen -- Proliferation -- Proteases -- R -- Remodeling -- Retina -- Revascularization -- S -- Screening -- Signal transduction -- Smooth muscle cell (SMC) -- Surrogate marker -- T -- Tecogalan 11, 145, 153, 155, 157 -- Therapeutic angiogenesis -- Thrombospondin -- Thymosin -- Tube formation -- Tumor angiogenesis -- Tyrosine kinase -- V -- Vascular remodeling -- VEGF -- VEGF receptors -- W -- Wound angiogenesis.
0
8
8
8
SUMMARY OR ABSTRACT
Text of Note
The regulation of blood vessel growth underlies many normal biological processes such as reproduction, development, repair and wound healing. It also is a critical feature of pathological processes such as cancer, diabetic retinopathy, macular degeneration, inflammatory arthritis and ischemic heart disease.
SYSTEM REQUIREMENTS NOTE (ELECTRONIC RESOURCES)
Text of Note
Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
OTHER EDITION IN ANOTHER MEDIUM
Title
Angiogenesis inhibitors and stimulators.
International Standard Book Number
1587060221
TOPICAL NAME USED AS SUBJECT
Growth factors.
Neovascularization inhibitors.
Neovascularization.
Angiogenesis Inhibitors-- therapeutic use.
Growth Substances.
Neovascularization, Pathologic.
Growth factors.
MEDICAL-- Physiology.
Neovascularization inhibitors.
Neovascularization.
SCIENCE-- Life Sciences-- Human Anatomy & Physiology.
(SUBJECT CATEGORY (Provisional
MED-- 075000
SCI-- 036000
DEWEY DECIMAL CLASSIFICATION
Number
612
.
1/3
Edition
21
LIBRARY OF CONGRESS CLASSIFICATION
Class number
QP106
.
6
Book number
.
A525
2000eb
OTHER CLASS NUMBERS
Class number
QU
107
Book Number
A5876
2000
PERSONAL NAME - ALTERNATIVE RESPONSIBILITY
Mousa, Shaker A.
ORIGINATING SOURCE
Date of Transaction
20201203075039.0
Cataloguing Rules (Descriptive Conventions))
pn
ELECTRONIC LOCATION AND ACCESS
Electronic name
مطالعه متن کتاب [Book]
Y
